CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

PTEN

CIViC ID: 41 · Entrez: 5728

Aliases: 10q23del,BZS,CWS1,DEC,GLM2,MHAM,MMAC1,PTEN1,TEP1,PTEN,PTENbeta,PTENgama

Description

PTEN is a multi-functional tumor suppressor that is very commonly lost in human cancer. Observed in prostate cancer, glioblastoma, endometrial, lung and breast cancer to varying degrees. Up to 70% of prostate cancer patients have been observed to have loss of expression of the gene. It is a part of the PI3K/AKT/mTOR pathway and mTOR inhibitors have been relatively ineffective in treating patients with PTEN loss. New appoaches using microRNAs are currently being investigated.

Cyan = gene  ·  Slate = variant  ·  Green = drug  ·  Click variant to filter table

Variants (9)

CIViC IDNameHGVSType(s)
3382C136R
213Deletiontranscript_ablation
313Expression
214Lossloss_of_function_variant
510Mutationprotein_altering_variant
636R130*
R130X,ARG130TER,RS121909224
NM_000314.6:c.388C>T,NP_000305.3:p.Arg130Ter,ENST00000371953.3:c.388C>T,NC_000010.10:g.89692904C>Tstop_gained
838R173C
ARG173CYS,RS121913293
NM_000314.6:c.517C>T,NP_000305.3:p.Arg173Cys,ENST00000371953.3:c.517C>T,NC_000010.10:g.89711899C>Tmissense_variant
110R233*
R233X,ARG233TER,RS121909219
NM_000314.6:c.697C>T,NP_000305.3:p.Arg233Ter,ENST00000371953.3:c.697C>T,NC_000010.10:g.89717672C>Tstop_gained,loss_of_function_variant
605V317FS
VAL317FS
ENST00000371953.3:c.950_953delTACT,NC_000010.10:g.89720799_89720802delframeshift_variant